6WNK
Macrocyclic peptides TDI5575 that selectively inhibit the Mycobacterium tuberculosis proteasome
Summary for 6WNK
Entry DOI | 10.2210/pdb6wnk/pdb |
Related PRD ID | PRD_002377 |
Descriptor | Proteasome subunit alpha, Proteasome subunit beta, (12S,15S)-N-[(2-fluorophenyl)methyl]-10,13-dioxo-12-{2-oxo-2-[(2R)-2-phenylpyrrolidin-1-yl]ethyl}-2-oxa-11,14-diazatricyclo[15.2.2.1~3,7~]docosa-1(19),3(22),4,6,17,20-hexaene-15-carboxamide, ... (6 entities in total) |
Functional Keywords | mycobacterium tuberculosis, proteasome inhibitor, macrocyclic peptides, hydrolase, hydrolase-hydrolase inhibitor complex, hydrolase/hydrolase inhibitor |
Biological source | Mycobacterium tuberculosis More |
Total number of polymer chains | 28 |
Total formula weight | 730000.32 |
Authors | |
Primary citation | Zhang, H.,Hsu, H.C.,Kahne, S.C.,Hara, R.,Zhan, W.,Jiang, X.,Burns-Huang, K.,Ouellette, T.,Imaeda, T.,Okamoto, R.,Kawasaki, M.,Michino, M.,Wong, T.T.,Toita, A.,Yukawa, T.,Moraca, F.,Vendome, J.,Saha, P.,Sato, K.,Aso, K.,Ginn, J.,Meinke, P.T.,Foley, M.,Nathan, C.F.,Darwin, K.H.,Li, H.,Lin, G. Macrocyclic Peptides that Selectively Inhibit the Mycobacterium tuberculosis Proteasome. J.Med.Chem., 64:6262-6272, 2021 Cited by PubMed Abstract: Treatment of tuberculosis (TB) currently takes at least 6 months. Latent (Mtb) is phenotypically tolerant to most anti-TB drugs. A key hypothesis is that drugs that kill nonreplicating (NR) Mtb may shorten treatment when used in combination with conventional drugs. The Mtb proteasome (Mtb20S) could be such a target because its pharmacological inhibition kills NR Mtb and its genetic deletion renders Mtb unable to persist in mice. Here, we report a series of macrocyclic peptides that potently and selectively target the Mtb20S over human proteasomes, including macrocycle . The cocrystal structure of macrocycle with Mtb20S revealed structural bases for the species selectivity. Inhibition of 20S within Mtb by dose dependently led to the accumulation of Pup-tagged GFP that is degradable but resistant to depupylation and death of nonreplicating Mtb under nitrosative stress. These results suggest that compounds of this class have the potential to develop as anti-TB therapeutics. PubMed: 33949190DOI: 10.1021/acs.jmedchem.1c00296 PDB entries with the same primary citation |
Experimental method | X-RAY DIFFRACTION (2.28 Å) |
Structure validation
Download full validation report
